Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN   US75886F1075

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/25/2015 06/26/2015 06/29/2015 06/30/2015 07/01/2015 Date
519.24(c) 520.63(c) 504.97(c) 510.13(c) 506.51(c) Last
483 159 408 218 600 676 635 786 524 712 Volume
+0.51% +0.27% -3.01% +1.02% -0.71% Change
More quotes
Financials ($)
Sales 2015 3 725 M
EBIT 2015 1 433 M
Net income 2015 508 M
Finance 2015 1 263 M
Yield 2015 -
Sales 2016 4 470 M
EBIT 2016 1 951 M
Net income 2016 896 M
Finance 2016 3 142 M
Yield 2016 -
PER 2015 119,13
PER 2016 66,78
EV / Sales 2015 13,8x
EV / Sales 2016 11,1x
Capitalization 52 685 M
More Financials
Company
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company.It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.Regeneron markets medicines for eye diseases, colorectal cancer and a rare inflammatory condition and... 
Sector
Pharmaceuticals
Calendar
08/04Earnings Release
More about the company
Surperformance© ratings of Regeneron Pharmaceuticals
Trading Rating : Investor Rating :
More Ratings
Latest news on REGENERON PHARMACEUTICALS
03:22p REGENERON PHARMACEUTICALS : Robbins Arroyo LLP : Is Investigating Regeneron Phar..
03:03p REGENERON PHARMACEUTICALS : EYLEA® aflibercept Injection Receives Approval in Ja..
12:58p REGENERON PHARMACEUTICALS : Announces 2015 Winners of the Prize for Creative Inn..
06/29 REGENERON PHARMACEUTICALS : Rapid Response Platform for Emerging Infectious Dise..
06/26 New Sanofi CEO to unveil five-year plan in November - unions
06/26 REGENERON PHARMACEUTICALS : EYLEA® (aflibercept) Injection Receives Approval in ..
06/25 REGENERON PHARMACEUTICALS : Announces 2015 Winners of the Prize for Creative Inn..
06/23 REGENERON PHARMACEUTICALS : Federal Contracts Awarded by Federal Agencies in Ill..
More news
Sector news : Pharmaceuticals - NEC
05:25p California considering banning biodegradable microbeads from personal care pr..
04:31p GILEAD SCIENCES : Submits New Drug Application to U.S. Food and Drug Administrat..
04:06p JAZZ PHARMACEUTICALS : to Present at Cantor Fitzgerald Healthcare Conference on ..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
06/30 Biotech Investors Should Read Bibliographies Of Chief Scientific Officers
06/26 New indication for Regeneron's Eylea cleared in Japan
06/25 Regeneron's Growth Governed By 3 Key Prospects
06/23 Stocks To Buy On Greece Resolution - Cramer's Mad Money (6/22/15)
06/19 Is Biotech Finally In A Bubble?


Comments 
Advertisement
Chart REGENERON PHARMACEUTICALS
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions